Delek Logistics Partners, LP Increases Quarterly Cash Distribution to $1.11 per Common Limited Partner Unit
BRENTWOOD, Tenn.–(BUSINESS WIRE)–Delek Logistics Partners, LP (NYSE: DKL) (“Delek Logistics”) today declared its quarterly cash distribution for... Read more.
Surmodics to Report Second Quarter of Fiscal 2025 Financial Results on April 30
EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the... Read more.
NOV Reports First Quarter 2025 Results
Net Income of $73 million, or $0.19 per share, down $46 million year-over-year Adjusted EBITDA* of $252 million, an increase of $11 million year-over-year Cash flow... Read more.
ISS Joins Glass Lewis in Urging Parkland Shareholders to Vote For Meaningful Change
Highlights Troubling Pattern of Mismanagement, Volatile and Deteriorating Financial Performance, Failure to Execute, and Repeated Efforts to Disenfranchise Shareholders... Read more.
Sangoma Announces Date of Third Quarter Fiscal 2025 Financial Results and Conference Call
MARKHAM, Ontario–(BUSINESS WIRE)–Sangoma Technologies Corporation (TSX: STC; Nasdaq: SANG) (“Sangoma” or the “Company”), a trusted industry leader... Read more.
Affinia Therapeutics to Present New Data on its AFTX-201 Program in BAG3 Dilated Cardiomyopathy, BBB-Penetrant AAV Capsids, and Proprietary Manufacturing Technology at the 28th Annual American Society of Gene & Cell Therapy 2025 Annual Meeting
Company’s lead program, AFTX-201 in BAG3 dilated cardiomyopathy, on track for IND submission fourth quarter of 2025 with potential initial readouts of clinical... Read more.
Teradyne Reports First Quarter 2025 Results
Revenue towards the high end and earnings above Q1 guidance ranges Revenue of $686 million in Q1’25, up 14% from Q1’24 Strong year-over-year growth driven by... Read more.
WM Announces First Quarter 2025 Earnings
Strong Operational Performance Combined with WM Healthcare Solutions Results Deliver Outsized Growth WM Adds Two Recycling Automation Projects in Key Markets During... Read more.
Evolv Technology Completes Restatement of Previously Issued Financial Statements and Reports Third Quarter, Fourth Quarter and Full Year 2024 Financial Results
— Company Regains Compliance with SEC Reporting and NASDAQ Listing Requirements — — Company Achieves Positive Adjusted EBITDA1 in Q4’24 — Q4’24... Read more.
Calix Announces Upcoming Investor Events
SAN JOSE, Calif.–(BUSINESS WIRE)–Calix, Inc. (NYSE: CALX) today announced that Calix management will participate in the upcoming investor events: Event:... Read more.